Jasper Hellweg
Stock Analyst at Argus Research
(2.16)
# 2,871
Out of 4,974 analysts
87
Total ratings
49.3%
Success rate
4.1%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Downgrades: Hold | n/a | $140.67 | - | 4 | Apr 4, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $360 → $400 | $400.52 | -0.13% | 7 | Oct 31, 2024 | |
| ILMN Illumina | Upgrades: Buy | $150 | $98.93 | +51.62% | 7 | Aug 28, 2024 | |
| SNY Sanofi | Maintains: Buy | $55 → $60 | $46.50 | +29.03% | 2 | Jul 26, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,060 → $1,170 | $573.38 | +104.05% | 9 | Jun 25, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $465 → $550 | $396.12 | +38.85% | 7 | Jun 17, 2024 | |
| AZN AstraZeneca | Maintains: Buy | $80 → $85 | $81.70 | +4.04% | 3 | May 30, 2024 | |
| NVO Novo Nordisk | Maintains: Buy | $115 → $125 | $55.23 | +126.33% | 1 | Feb 1, 2024 | |
| MRNA Moderna | Maintains: Buy | $160 → $140 | $25.14 | +456.88% | 4 | Sep 13, 2023 | |
| ABBV AbbVie | Downgrades: Hold | n/a | $212.56 | - | 2 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $200 | $153.32 | +30.45% | 6 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $18.95 | - | 1 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $290 | $187.68 | +54.52% | 4 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $106.94 | -6.49% | 3 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $295 | $278.67 | +5.86% | 4 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.58 | - | 3 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $135 | $183.49 | -26.43% | 5 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $24.42 | - | 2 | Sep 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $22.65 | - | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $249.67 | - | 3 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $41.26 | - | 4 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $155 | $420.77 | -63.16% | 3 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $135.05 | -33.36% | 1 | Sep 19, 2018 |
Biogen
Apr 4, 2025
Downgrades: Hold
Price Target: n/a
Current: $140.67
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $400.52
Upside: -0.13%
Illumina
Aug 28, 2024
Upgrades: Buy
Price Target: $150
Current: $98.93
Upside: +51.62%
Sanofi
Jul 26, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $46.50
Upside: +29.03%
Regeneron Pharmaceuticals
Jun 25, 2024
Maintains: Buy
Price Target: $1,060 → $1,170
Current: $573.38
Upside: +104.05%
Vertex Pharmaceuticals
Jun 17, 2024
Maintains: Buy
Price Target: $465 → $550
Current: $396.12
Upside: +38.85%
AstraZeneca
May 30, 2024
Maintains: Buy
Price Target: $80 → $85
Current: $81.70
Upside: +4.04%
Novo Nordisk
Feb 1, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $55.23
Upside: +126.33%
Moderna
Sep 13, 2023
Maintains: Buy
Price Target: $160 → $140
Current: $25.14
Upside: +456.88%
AbbVie
Apr 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $212.56
Upside: -
Jun 17, 2022
Maintains: Buy
Price Target: $225 → $200
Current: $153.32
Upside: +30.45%
Jan 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $18.95
Upside: -
Sep 10, 2021
Maintains: Buy
Price Target: $260 → $290
Current: $187.68
Upside: +54.52%
Jun 9, 2021
Upgrades: Buy
Price Target: $100
Current: $106.94
Upside: -6.49%
May 20, 2021
Maintains: Buy
Price Target: $270 → $295
Current: $278.67
Upside: +5.86%
May 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $7.58
Upside: -
Oct 21, 2020
Upgrades: Buy
Price Target: $135
Current: $183.49
Upside: -26.43%
Sep 4, 2020
Downgrades: Hold
Price Target: n/a
Current: $24.42
Upside: -
Apr 17, 2020
Downgrades: Hold
Price Target: n/a
Current: $22.65
Upside: -
Apr 6, 2020
Downgrades: Hold
Price Target: n/a
Current: $249.67
Upside: -
Oct 30, 2019
Downgrades: Hold
Price Target: n/a
Current: $41.26
Upside: -
Nov 6, 2018
Maintains: Buy
Price Target: $150 → $155
Current: $420.77
Upside: -63.16%
Sep 19, 2018
Maintains: Buy
Price Target: $85 → $90
Current: $135.05
Upside: -33.36%